Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Badesch

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Chest|July 14, 2004
Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelinesDavid B Badesch, Steve H Abman, Gregory S Ahearn, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 3, 2014
Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: a Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysisRaymond L Benza, Dave P Miller, Aimee J Foreman, et al.
Chest|July 11, 2003
Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up studyOlivier Sitbon, David B Badesch, Richard N Channick, et al.
Psychosomatics|July 1, 2010
Depressive symptoms in pulmonary arterial hypertension: prevalence and association with functional statusDeborah H McCollister, Michelle Beutz, Vallerie McLaughlin, et al.
Chest|June 18, 2011
The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertensionRaymond L Benza, Mardi Gomberg-Maitland, Dave P Miller, et al.
Chest|May 29, 2010
Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotypeLorinda Chung, Juliana Liu, Lori Parsons, et al.
European Journal of Medical Research|May 26, 2006
Importance of right ventricular end-systolic regional wall stress in idiopathic pulmonary arterial hypertension: a new method for estimation of right ventricular wall stressRobert A Quaife, Marcus Y Chen, David Lynch, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 15, 2018
Use of supplemental oxygen in patients with pulmonary arterial hypertension in REVEALHarrison W Farber, David B Badesch, Raymond L Benza, et al.
Respiratory Medicine|December 12, 2024
Riociguat in pulmonary arterial hypertension: Application of the 4-strata COMPERA 2.0 risk assessment tool in the PATENT studiesMarius M Hoeper, Stephan Rosenkranz, David B Badesch, et al.
The Journal of Rheumatology|September 3, 2009
Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenolDavid B Badesch, Michael D McGoon, Robin J Barst, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Chest|July 14, 2004
Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelinesDavid B Badesch, Steve H Abman, Gregory S Ahearn, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 3, 2014
Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: a Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysisRaymond L Benza, Dave P Miller, Aimee J Foreman, et al.
Chest|July 11, 2003
Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up studyOlivier Sitbon, David B Badesch, Richard N Channick, et al.
Psychosomatics|July 1, 2010
Depressive symptoms in pulmonary arterial hypertension: prevalence and association with functional statusDeborah H McCollister, Michelle Beutz, Vallerie McLaughlin, et al.
Chest|June 18, 2011
The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertensionRaymond L Benza, Mardi Gomberg-Maitland, Dave P Miller, et al.
Chest|May 29, 2010
Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotypeLorinda Chung, Juliana Liu, Lori Parsons, et al.
European Journal of Medical Research|May 26, 2006
Importance of right ventricular end-systolic regional wall stress in idiopathic pulmonary arterial hypertension: a new method for estimation of right ventricular wall stressRobert A Quaife, Marcus Y Chen, David Lynch, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 15, 2018
Use of supplemental oxygen in patients with pulmonary arterial hypertension in REVEALHarrison W Farber, David B Badesch, Raymond L Benza, et al.
Respiratory Medicine|December 12, 2024
Riociguat in pulmonary arterial hypertension: Application of the 4-strata COMPERA 2.0 risk assessment tool in the PATENT studiesMarius M Hoeper, Stephan Rosenkranz, David B Badesch, et al.
The Journal of Rheumatology|September 3, 2009
Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenolDavid B Badesch, Michael D McGoon, Robin J Barst, et al.
Pageof 9